CTXR · Citius Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| Carol Webb Director | ▼ Sell | Tax Withholding | 11,835 Shares held | 3/4/2024 | View profile |
| Eugene Myron Holuka Director | ▼ Sell | Tax Withholding | 2,367 Shares held | 3/13/2024 | View profile |
Transaction History
| Eugene Myron Holuka | ▼ Sell | Tax Withholding | 48 | $36 | 3/13/2024 |
| Eugene Myron Holuka | ▲ Buy | Option Exercise | 2,415 | $36 | 3/13/2024 |
| Carol Webb | ▲ Buy | Option Exercise | 12,071 | $181 | 3/4/2024 |
| Carol Webb | ▼ Sell | Tax Withholding | 236 | $181 | 3/4/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CTXR to Attend Investor Conferences in Oct 2026
Citius Pharmaceuticals will attend investor conferences in October 2026, allowing shareholders to hear about future plans. The event may raise the company’s visibility and give management a platform to discuss strategy. The announcement does not alter current trading levels but could affect investor interest.
CTXR to Attend Investor Conferences in Oct 2026. Citius Pharmaceuticals will attend investor conferences in October 2026, allowing shareholders to hear about future plans. The event may raise the company’s visibility and give management a platform to discuss strategy. The announcement does not alter current trading levels but could affect investor interest.